Literature DB >> 18954885

Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles.

Johnathan Storlie1, John E Carpenter, Wallen Jackson, Charles Grose.   

Abstract

Because of its very low titer, varicella-zoster virus (VZV) infectivity is usually transferred by passage of trypsin dispersed infected cells. Previously, we observed that gC biosynthesis was markedly delayed in monolayers inoculated with cell free virus. In this report, we investigated the kinetics of gC expression in more detail and included studies of monolayers inoculated with trypsin dispersed infected cells, the more traditional method of VZV infection. Extensive imaging analyses disclosed that gC was detectable in some inoculum cells, but little gC biosynthesis occurred during the first 48 hpi in the newly infected underlying monolayer. In contrast, during the first 24-48 hpi, expression of VZV gE and gB was easily detectable. Using real-time RT-PCR, we found a delay in accumulation of VZV gC transcripts that paralleled the delay in expression of VZV gC protein. Treatment with hexamethylene bisacetamide (HMBA) increased expression of both gC protein and gC mRNA. HMBA treatment also increased virus titer by 4-fold, but paradoxically reduced plaque size in the titration assay. Finally, we examined skin vesicles from cases of chickenpox and zoster in humans and observed abundant amounts of gC expression. In short, this report documents an unexpected delay in both gC mRNA and protein production under all conditions of VZV infection of cultured cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18954885      PMCID: PMC2754791          DOI: 10.1016/j.virol.2008.09.031

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  34 in total

1.  Biological characteristics of Marek's disease vaccine CVI-988 clone C1.

Authors:  G F de Boer; J M Pol; H L Oei
Journal:  Vet Q       Date:  1987-11       Impact factor: 3.320

2.  A possible role for glycoprotein gpV in the pathogenesis of varicella-zoster virus.

Authors:  P R Kinchington; P Ling; M Pensiero; A Gershon; J Hay; W T Ruyechan
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

Review 3.  Regulation of expression of the glycoprotein genes of herpes simplex virus type 1 (HSV-1).

Authors:  M Levine; A Krikos; J C Glorioso; F L Homa
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

Review 4.  Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking.

Authors:  C Grose
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

5.  The effect of elevated levels of herpes simplex virus alpha-gene products on the expression of model early and late genes in vivo.

Authors:  Y F Zhang; G B Devi-Rao; M Rice; R M Sandri-Goldin; E K Wagner
Journal:  Virology       Date:  1987-03       Impact factor: 3.616

6.  Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140).

Authors:  E A Montalvo; C Grose
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

7.  The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka).

Authors:  P R Kinchington; P Ling; M Pensiero; B Moss; W T Ruyechan; J Hay
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

8.  Monoclonal antibodies against three major glycoproteins of varicella-zoster virus.

Authors:  C Grose; D P Edwards; W E Friedrichs; K A Weigle; W L McGuire
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

Review 9.  Intracellular synthesis of varicella-zoster virus.

Authors:  C Grose; T I Ng
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

10.  Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles.

Authors:  K A Weigle; C Grose
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

View more
  17 in total

1.  Aberrant virion assembly and limited glycoprotein C production in varicella-zoster virus-infected neurons.

Authors:  Charles Grose; Xiaoli Yu; Randall J Cohrs; John E Carpenter; Jacqueline L Bowlin; Don Gilden
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

2.  Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection.

Authors:  Stefan L Oliver; Edward Yang; Ann M Arvin
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

3.  Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis.

Authors:  Stefan L Oliver; Edward Yang; Ann M Arvin
Journal:  Curr Clin Microbiol Rep       Date:  2016-09-09

4.  The Structures and Functions of VZV Glycoproteins.

Authors:  Stefan L Oliver
Journal:  Curr Top Microbiol Immunol       Date:  2021-11-04       Impact factor: 4.737

5.  Varicella-zoster virus infection induces autophagy in both cultured cells and human skin vesicles.

Authors:  Marie-Noëlle Takahashi; Wallen Jackson; Donna T Laird; Timothy D Culp; Charles Grose; John I Haynes; Luca Benetti
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

6.  COMMENTARY: Significantly less anti-gC antibody detectable in sera collected after varicella vaccination than after the disease varicella.

Authors:  Charles Grose; Young Juhn
Journal:  Pediatr Infect Dis J       Date:  2012-11       Impact factor: 2.129

7.  Autophagy and the effects of its inhibition on varicella-zoster virus glycoprotein biosynthesis and infectivity.

Authors:  Erin M Buckingham; John E Carpenter; Wallen Jackson; Charles Grose
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

8.  The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation.

Authors:  Geoffrey A Peters; Shaun D Tyler; John E Carpenter; Wallen Jackson; Yasuko Mori; Ann M Arvin; Charles Grose
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

9.  Enumeration of an extremely high particle-to-PFU ratio for Varicella-zoster virus.

Authors:  John E Carpenter; Ernesto P Henderson; Charles Grose
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

10.  Cellular Stress Response to Varicella-Zoster Virus Infection of Human Skin Includes Highly Elevated Interleukin-6 Expression.

Authors:  Keith W Jarosinski; John E Carpenter; Erin M Buckingham; Wallen Jackson; Kevin Knudtson; Jennifer F Moffat; Hirohito Kita; Charles Grose
Journal:  Open Forum Infect Dis       Date:  2018-05-22       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.